JPS4942518B1 - - Google Patents
Info
- Publication number
- JPS4942518B1 JPS4942518B1 JP41047428A JP4742866A JPS4942518B1 JP S4942518 B1 JPS4942518 B1 JP S4942518B1 JP 41047428 A JP41047428 A JP 41047428A JP 4742866 A JP4742866 A JP 4742866A JP S4942518 B1 JPS4942518 B1 JP S4942518B1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
- C07D499/46—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with acyclic hydrocarbon radicals or such radicals substituted by carbocyclic or heterocyclic rings, attached to the carboxamido radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US473834A US3322749A (en) | 1965-07-21 | 1965-07-21 | Derivatives of penicillanic acid and cephalosporanic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS4942518B1 true JPS4942518B1 (ja) | 1974-11-15 |
Family
ID=23881194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP41047428A Pending JPS4942518B1 (ja) | 1965-07-21 | 1966-07-21 |
Country Status (5)
Country | Link |
---|---|
US (1) | US3322749A (ja) |
JP (1) | JPS4942518B1 (ja) |
BR (2) | BR6681457D0 (ja) |
DE (2) | DE1670115A1 (ja) |
GB (2) | GB1138768A (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1259294A (ja) * | 1968-07-09 | 1972-01-05 | ||
AR208171A1 (es) * | 1972-09-29 | 1976-12-09 | Ciba Geigy Ag | Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico |
US4683227A (en) * | 1985-07-09 | 1987-07-28 | Eli Lilly And Company | Antibiotic derivatives of 7β-[2-(thiazol-4-yl)acetamide]-3-chloro-3-cephem-4-carboxylic acids and compositions and method of use thereof |
-
1965
- 1965-07-21 US US473834A patent/US3322749A/en not_active Expired - Lifetime
-
1966
- 1966-07-20 DE DE19661670115 patent/DE1670115A1/de active Pending
- 1966-07-21 GB GB32792/66A patent/GB1138768A/en not_active Expired
- 1966-07-21 JP JP41047428A patent/JPS4942518B1/ja active Pending
- 1966-07-21 BR BR181457/66A patent/BR6681457D0/pt unknown
- 1966-07-21 GB GB32826/66A patent/GB1141621A/en not_active Expired
- 1966-07-21 DE DE19661670117 patent/DE1670117A1/de active Pending
- 1966-07-21 BR BR181458/66A patent/BR6681458D0/pt unknown
Also Published As
Publication number | Publication date |
---|---|
DE1670115A1 (de) | 1970-08-13 |
GB1138768A (en) | 1969-01-01 |
US3322749A (en) | 1967-05-30 |
BR6681458D0 (pt) | 1973-11-29 |
DE1670117A1 (de) | 1970-08-13 |
GB1141621A (en) | 1969-01-29 |
BR6681457D0 (pt) | 1973-10-25 |